Fingolimod Withdrawn Phase 4 Trials for Disseminated Sclerosis Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT01621269ENGYNE Exploring Gilenya in Patients With Neutralizing Antibodies Against Interferon